Submitted by reuters8361 in business
Belgium has decided to temporarily ban the use of Novo Nordisk's <a href="https://www.reuters.com/markets/companies/NOVOb.CO" target="_blank">(NOVOb.CO)</a> diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, according to a royal…